Clinical trialNCT06576271RecruitingPhase 1Interventional

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

SponsorGlaxoSmithKlineEnrollment142Systemic Lupus Erythematosus

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

GSK Clinical Trials
GlaxoSmithKline
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Gsk Investigational Site
Buenos Aires, Argentina
Damian Duartes Noe
Recruiting
Gsk Investigational Site
Rosario, Argentina
Marina Carcamo Diaz
Recruiting
Gsk Investigational Site
San Juan Bautista, Argentina
Julia Papagno
Recruiting
Gsk Investigational Site
San Miguel de Tucumán, Argentina
Francisco Colombres
Recruiting

Brazil

Gsk Investigational Site
Porto Alegre, Rio Grande do Sul, Brazil
Odirlei Andre Monticielo
Recruiting
Gsk Investigational Site
Juiz de Fora, Brazil
Viviane Souza
Recruiting
Gsk Investigational Site
Porto Alegre, Brazil
Mauro Keiserman
Recruiting
Gsk Investigational Site
Salvador, Brazil
Adriane da Paz
Recruiting

Poland

Gsk Investigational Site
Bydgoszcz, Poland
Katarzyna Kolossa
Recruiting
Gsk Investigational Site
Krakow, Poland
Mariusz Korkosz
Recruiting
Gsk Investigational Site
Poznan, Poland
Wlodzimierz Samborski
Recruiting
Gsk Investigational Site
Warsaw, Poland
Anna Zubrzycka Sienkiewicz
Recruiting
Gsk Investigational Site
Wroclaw, Poland
Piotr Wiland
Recruiting

Spain

Gsk Investigational Site
Barcelona, Spain
Ivette Casafont Sole
Recruiting
Gsk Investigational Site
Bilbao, Spain
Esther RUIZ LUCEA
Recruiting
Gsk Investigational Site
Pamplona, Spain
Patricia Fanlo
Recruiting
Gsk Investigational Site
Sabadell Barcelona, Spain
Joan Calvet Fontova
Recruiting
Gsk Investigational Site
Valladolid, Spain
Maria Julia Barbado Ajo
Recruiting

United Kingdom

Gsk Investigational Site
Cambridge, United Kingdom
Michalis Kostapanos
Recruiting
Gsk Investigational Site
Liverpool, United Kingdom
Richard Fitzgerald
Recruiting
Gsk Investigational Site
London, United Kingdom
Philip Molyneaux
Recruiting
Gsk Investigational Site
Middlesex, United Kingdom
Rajni Vekaria
Recruiting

United States

Gsk Investigational Site
Scottsdale, Arizona, United States
Withdrawn
Gsk Investigational Site
Aurora, Colorado, United States
Christopher Striebich
Recruiting
Gsk Investigational Site
Las Vegas, Nevada, United States
Walter Chatham
Recruiting
Gsk Investigational Site
Columbus, Ohio, United States
Judith Lin
Recruiting
Gsk Investigational Site
Oklahoma City, Oklahoma, United States
Withdrawn
Gsk Investigational Site
Dallas, Texas, United States
Withdrawn

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Sept 2024
Primary completion: 11 Jan 2028
Completion: 11 Jan 2028
Last update posted: 22 Jun 2026
Registered enrollment: 142
Registry id: NCT06576271

Cross-registrations

EU-CTR / CTIS (EudraCT)2024-514186-18-00

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.